Introduction structure has been solved (13) , shows that it is a bi-lobal protein consisting of four distinct domains (D1-4), three of which are rich in β-sheet structure ( Figure 1 ). The small lobe of aerolysin is missing from the amino terminus in AT and this implies that AT is a single-lobed structure consisting of three domains that are homologous to D2-D4 of aerolysin ( Figure 1 ). The small lobe of aerolysin (D1) contains a lectin-binding domain that enables it to bind to various receptors that are not recognized by AT (14, 15) . However, fusion of D1 of aerolysin to the amino terminus of AT converts it to a molecule with aerolysin-like receptor specificity and activity (15) . Comparatively little is known about the cytolytic mechanism of enterolobin, but its primary structure appears to be more related to aerolysin than AT. Enterolobin displays sequence similarity with both the small and large lobes of aerolysin and appears to form a dimer in solution (6, 16) .
Although many aspects of the cytolytic mechanism of AT and aerolysin have been elucidated, the domain(s) of these toxins directly involved in the formation of the pore have yet to be identified. Two structural motifs used by pore-forming toxins to span membranes are amphiphatic β-strands and α-helices. Both motifs have been identified in toxins as the secondary structures used to cross the membrane during pore formation. For example, the pore-forming domain of the colicins and the T-domain of diphtheria toxin use a pair of amphipathic α-helices to span the membrane (17, 18) , whereas the protective antigen component of anthrax toxin (19) , the α-hemolysin from Staphylococcus aureus (20, 21) , and perfringolysin O from Clostridium perfringens (22, 23) all use amphipathic β-strands that contribute to the formation of a transmembrane β-barrel ( Figure 1 ). However, identification of the TMD has not been necessarily easy or without controversy. The TMD of the cholesterol-dependent cytolysins (CDCs) was first suggested to be comprised of a β-sandwich (24) , or an amphipathic α-helix (25) and Gilbert et al. (26) suggested that the CDCs did not penetrate the membrane at all. The pore-forming region of the CDCs was unambiguously shown to be comprised of 2 amphipathic β-hairpins located in D3 of the perfringolysin O crystal structure that are derived from 6 short α-helices of the soluble monomer (22) (23) (24) .
It was previously hypothesized that the D4 β-sandwich of aerolysin penetrates the membrane and forms the TMD of aerolysin (13) . More recently, Tsitrin et al. (27) also suggested that the D4 β-sandwich forms the TMD of aerolysin based on an electron density map of what was proposed to be a soluble oligomer of aerolysin.
However, to date, no experimental data have been reported that directly demonstrate the interaction of a specific region of aerolysin, or the related AT or enterolobin, with the membrane.
The aerolysin-based structural model of AT and the aerolysin crystal structure exhibit a conspicuous amphipathic loop that is found in D2 of AT and the corresponding D3 of aerolysin ( Figure 1 ). Using multiple fluorescent and biochemical approaches we have confirmed that this amphipathic loop in D2 of AT, comprised of residues K203 to Q232, forms an amphipathic β-hairpin that spans the membrane and is necessary for pore formation. Similar analyses of residues in the D3 β-sandwich of AT, corresponding to the D4 region of aerolysin indicates that it is only peripherally associated with the membrane and is unlikely to participate directly in the formation of the transmembrane β-barrel.
Experimental Procedures
Bacterial strains, plasmids, cell lines, and chemicals. The gene for AT was cloned into Gibco BRL (Rockville, MD) unless otherwise specified.
Generation of deletion and point mutations. All deletion mutations in AT were generated using a four-primer site-directed PCR mutagenesis procedure previously described (29) except that pBRS10 was used as the template and pfu turbo thermostable polymerase (Stratagene, La Jolla, CA) was substituted for taq. PCR overlap products were purified using the Quantum-Prep PCR Kleen Spin columns (Bio-Rad, Hercules, CA), digested with NcoI and XhoI, and ligated into pET-22(b)+ digested with NcoI and
XhoI.
An active, cysteine-less derivative of AT, termed AT C86A , was generated using the above mutagenesis procedure and the resulting plasmid was designated pBRS20.
All cysteine substitutions were produced using pBRS20 as template, using either the four-primer PCR mutagenesis procedure above or QuikChange site-directed mutagenesis (Stratagene).
Expression and purification of AT. The growth and harvesting of E. coli BLR-DE3 expressing polyhistidine-tagged native AT and the various AT derivatives was performed according to Sellman et al. (28) . The cell pellets were resuspended in 150 ml of buffer A (10 mM MES (2-(N-morpholino)ethanesulphonic acid) (Research Organics, Cleveland OH), 150 mM NaCl, pH 6.5). Lysis of cells was carried out in an EmulsiFlex-C5 high pressure homogenizer (Avestin, Ottawa, ON, Canada) at 15,000 psi. Cell debris was removed by centrifugation at 21,000 x g for 10 min. Purification of the His-tagged AT from the supernatant was accomplished using a cobalt-chelating column and cation-exchange column was done as previously described (28) . AT-containing fractions eluted from the cation-exchange column were combined in a Micro-ProDiCon System (Spectrum, Gardena, CA) with a 10,000 MWCO Micro-ProDiCon membrane for simultaneous dialysis and concentration. Samples were dialyzed against 10 mM MES, 500 mM NaCl, 1 mM EDTA, pH 6.5 (buffer B) overnight at 4°C. For cysteine-substituted proteins, 1 mM dithiothreitol was included in the dialysis buffer. 10% glycerol was added to the concentrated toxin before storage at -80°C. Protein concentration was determined by absorbance at 280 nm using a molar extinction coefficient of 63,000 M -1 cm -1 (Tweten, unpublished data). The model was built in two stages: (i) identification of significant regions of sequence identity between AT and aerolysin, and assigning coordinates to these regions, (ii) assigning coordinates to the homology model where the sequence identity to aerolysin is less convincing using a database of peptide fragments. The models were visually checked to remove any steric clashes within the software package 'O' (30), using the lego side chain and lego main chain options. This was followed by energy minimisation (500 cycles of Powell minimisation with tight harmonic restraints on the Cα atoms, followed by 500 cycles with no harmonic restraints) using X-PLOR (v. 10 µg preactivated toxin was incubated alone (monomer) or in the presence of 50 µl SupT1 membranes (oligomeric) and brought up to 400 µl final volume with buffer C. All samples were incubated overnight at 37°C in the dark to allow binding, oligomerization and insertion to go to completion. For intensity measurements, reactions were placed into quartz cuvettes (1 cm x 1 cm) filled with 1.6 ml buffer C at 37°C and placed into the spectrofluorometer set at a constant temperature of 37°C. Residues K203 to Q232 were individually mutated to cysteines, and the proteins were purified and labeled with NBD. The FI of each NBD-labeled mutant was examined in the absence and presence of SupT1 cell-derived membranes that contain a receptor(s) for AT (7) . Figure 2 shows example emission scans from adjacent residues, E227 and F228, in the monomeric and membrane-bound forms. In an amphipathic β-hairpin the side chain of F228 is predicted to interact with the bilayer during pore formation, while the side chain of E227 is predicted to reside in the hydrophilic channel of the pore. Consistent with this prediction, no significant increase in FI was seen for AT E227C-NBD following its incubation with membranes (Figure 2A ), whereas the FI of AT F228C-NBD increased approximately three-fold under the same conditions ( Figure 2B ).
SupT1 Membrane
The combined fluorescence data for NBD when attached to the individual cysteines that were substituted for all residues within this region are summarized in Figure 2C . The change in the emission intensity of NBD was determined from the ratio of the FI in the membrane-bound (F memb ) and soluble (F soluble ) states. These data reveal an alternating pattern of FI in which the side chains of these residues appear to weave in and out of a nonpolar environment. The pattern is most dramatic between residues K203 to K211 and E223 to E231.
Residues of AT domain 2 span the membrane. While an increase in the FI of NBD indicates movement of the NBD into a nonpolar environment such as the bilayer, it
does not necessarily confirm the location of the labeled residue in the bilayer. The membrane location of those residues shown to enter a nonpolar environment was confirmed by collisional quenching analysis. Nitroxides are efficient quenching agents of NBD as previously shown by Shepard et al. (22) , and when attached to the fatty acyl chain of stearic acid, nitroxides can be introduced into natural membranes and will only quench fluorophores exposed to the bilayer core (22, 23) .
As seen in Figure 3 , the pattern of quenching by DOXYL-stearic acid (DSA) was consistent with the alternating periodicity previously seen for the FI in Figure 2 . The greatest level of quenching was seen between residues G205 and E231. V212, which did not show an increase in FI on membranes, was quenched significantly by the membrane-restricted nitroxide. This observation suggests that the V212 side chain initially resides in a nonpolar environment in the soluble monomer of AT, so the FI of the NBD-modified cysteine at this position does not change significantly as the side chain moves from its nonpolar location in the soluble monomer to its position in the membrane.
Based on the pattern of quenching, E215 and I217 would be expected to face the channel where they would not come into contact with the quencher, however, both exhibit a small degree of quenching when incubated with these membranes. Since the alternating pattern is lost at this point and then resumes at residue A218, it is possible that the turn region connecting the 2 transmembrane β-strands may exist within the span of residues from 215 to 218, and as a result, these residues may be only partially exposed to the membrane.
The cytolytic activity of each of the NBD-labeled mutants was tested on SupT1 cells. Of the 30 residues mutated and labeled in D2, fifteen retained 25% or greater activity, twelve retained 5-25% activity, and three retained <1% activity (data not shown). Those mutants that lost 99% or greater activity are indicated in Figures 2 and 3 and each are predicted to face the membrane when inserted (I204, F210, and F226).
Due to the severe loss of activity by these mutants, they were not characterized further.
Deletion of residues between K203 and Q232 abolishes pore formation. Based on the molecular model of AT (Figure 1 ) it appears that deletion of the amphipathic loop would not significantly affect folding of AT, since it does not appear to be a core domain with extensive contacts. We therefore hypothesized that deletion of these residues would only disrupt pore formation if the residues are in the membrane-spanning region.
Three mutants within this region were constructed, deleting increasing lengths of the Figure 5A ). In vitro activation by trypsin also did not yield peptides that were not found after activation of the native toxin in solution (data not shown). Hence, the general structure of these mutants was apparently not altered to an extent that resulted in the exposure of new trypsin sites.
Formation of a disulfide bond between the TMD and the β-sheet backbone of D2 prevents pore formation. Previous studies on the analogous loop region in D3 of aerolysin showed that it could be tethered to the backbone of the molecule by means of a disulfide bond between the loop and the backbone of the molecule (34). Once formed, the disulfide prevented oligomerization and pore formation until it was reduced with dithiothreitol (DTT). From these studies, it was concluded that the loop region must move away from the D3 β-sheet in order for aerolysin to form a stable heptamer and generate pores in membranes.
A similar experiment was performed with AT, in which residues analogous to those mutated to cysteine in aerolysin (based on the AT structural model in Figure 1) were replaced with cysteines. Purified AT S220C-S269C was found to be inactive in its oxidized form, but exhibited >80% of the activity of native toxin when reduced (data not shown). When activated by trypsin and incubated with SupT1 membranes, AT S220C-S269C bound and oligomerized on SupT1 cells under both reducing and non-reducing conditions in a manner similar to native AT ( Figure 5B ). Thus movement of the loop region in D2 of AT is only necessary for pore formation and not binding or oligomerization.
Domain 3 residues of AT do not appear to span the bilayer. The TMD of aerolysin was originally proposed to be comprised of the D4 β-sandwich which formed a hydrophobic dagger that penetrated the membrane (13) . This idea has been reiterated in a recent study of an aerolysin mutant that forms a water-soluble heptamer, in which an aromatic belt was said to distinguish the upper boundary of a transmembrane region that was proposed to be present behind the propeptide (27) . Since D4 of aerolysin is homologous to D3 of AT, we examined residues within this region of AT to determine if they interact with the membrane during pore formation.
Two hydrophobic residues in D4 of aerolysin, L277 and L196, were suggested to interact with the membrane when pores are formed. These residues border three aromatic residues on different β-strands within D4 ( Figure 6A ), which were proposed (27) to make up an aromatic belt as is found in porins (35) . L277 and L196 reside on two different β-strands in aerolysin ( Figure 6A ) and are not conserved in AT. For L277 of aerolysin, the equivalent residue in AT is a glutamic acid at position 246 ( Figure 6B ), whereas for L196, the homologous residue is a proline at position 162 ( Figure 6B ). As P162 represented a more conservative change, we mutated it to a cysteine and labeled the mutant with NBD. When labeled with NBD and incubated in the presence of membranes, AT P162C-NBD displays a slight increase in FI that is not quenched upon addition of DSA to the membranes ( Figure 6C ), suggesting that it does not interact with the membrane during pore formation.
Five β-strands extend between D2 and D3 of AT ( Figure 6B ). P162 lies on one of these β-strands (β-strand 1, Figure 6B ) near the predicted D2-D3 junction. Seven residues downstream of P162 were examined on the same β-strand, which spans the length of the D3 β-sandwich of AT behind the propeptide, to determine if any of the residues within this region interact with the membrane. If D3 entered the membrane then these residues, which are on the same face as the predicted location of the propeptide, should interact with the membrane after toxin activation. These residues were analyzed in the same fashion as for those in Figures 2 and 3 . As seen in Figure   6C , all of the residues tested on this β-strand, except AT L163C-NBD , display at least a 2-fold increase in FI on membranes compared to the soluble monomer. When incubated with membranes containing the membrane restricted collisional quenching agent DSA, most of the residues exhibited little or no quenching indicating that these residues do not interact with the membrane to a significant extent.
As described above, E246 of AT, corresponding to L277 of aerolysin, was also predicted to interact with the membrane (27) . This residue is on a different β-strand than P162 (β-strand 2, Figure 6B ). We examined two consecutive residues downstream of E246 to determine if this strand interacts with the membrane during pore formation.
Using the same techniques as above, both residues showed an increase in FI upon incubation with SupT1 membranes (Figure 6C ), but displayed little or no quenching when DSA was present in the bilayer. L264, which resides on β-strand 3 in the middle of D3 of AT ( Figure 6B ), lies directly behind the propeptide. Residues on this strand are predicted to be masked by the propeptide until its dissociation and are immediately below one of the residues of the putative aromatic belt. AT L264C-NBD showed a very slight increase in FI that was not quenched on membranes containing DSA ( Figure 6C ).
Therefore, the residues of the D4 β-strands do not appear to have significant interactions with the membrane.
Discussion
The The fluorescence data were supported by deletion analysis of the putative TMD.
Based on the crystal structure of the related aerolysin and the aerolysin-based molecular model of AT (Figure 1 ), we predicted that deletion of the transmembrane loop from AT would not significantly alter the folding pattern of AT and should have left intact its ability to bind receptor, undergo proteolytic activation and to form membrane oligomers. As expected, these mutants retained all the functions of native toxin, except that they were unable to form a pore and lyse cells. Similar results were observed for anthrax protective antigen when its transmembrane loop was deleted (36) . Therefore, this region is necessary to the formation of the AT pore, but not for the other toxin functions that lead to pore formation.
In order to insert into the membrane this loop apparently moves away from the D2 backbone β-sheet. Rossjohn et al. (34) had previously shown that the introduction of a disulfide into aerolysin by the substitution of residues T253 and A300 with cysteines prevented pore formation. This disulfide locked the D3 loop region in aerolysin to the D3 β-sheet. They found that this disulfide prevented oligomerization of aerolysin and
proposed that this loop must move in order for aerolysin to become insertion competent.
Upon reduction of the disulfide, the disulfide-trapped aerolysin regained its cytolytic activity. Based on the molecular model of AT, the analogous residues of AT were mutated to cysteines. As expected, the structurally analogous disulfide in AT prevented pore formation when oxidized. However, like the deletion mutants, it retained the ability to bind membranes, undergo proteolytic activation and to form SDS-resistant oligomers. Also, like the aerolysin disulfide-trapped mutant, AT S220C-S269C regained nearly full cytolytic activity when the disulfide was reduced. Therefore, it also appears that this D2 transmembrane loop must move away from the backbone of AT to allow the β-hairpin to insert into the membrane.
One important difference between the aerolysin and AT disulfide mutants should be noted. We found that AT S220C-S269C can oligomerize when the engineered disulfide is oxidized, while disulfide mutant of aerolysin does not appear to oligomerize (34). This difference may reflect the fact that aerolysin exists as a head-to-tail dimer in solution (13) , whereas AT exists as a monomer (Melton and Tweten, unpublished data), and so the aerolysin dimer must dissociate prior to oligomerization. Aerolysin dimer formation is, in part, mediated via its small lobe (13, 37) which is missing in AT. When the small lobe is removed from aerolysin-like AT, it exists as a monomer in solution (37) . Therefore, it appears that the movement of the D3 loop of aerolysin may also be necessary for the disruption of the aerolysin dimer after receptor-binding (38) .
Is the amphipathic structure of the AT TMD conserved in aerolysin and enterolobin? Both aerolysin and enterolobin maintain an amphipathic structure that is located in their primary structures and is positionally conserved with that of AT ( Figure   7 ). Although enterolobin contains an arginine in the middle of the predicted hairpin, this residue may reside near the predicted turn and face the aqueous milieu. However, it could also penetrate the membrane with the aliphatic part of the side chain and snorkel the charged amine to the surface, similar to that found in the perfringolysin O TMDs (22) . Hence, it appears reasonable that like AT, aerolysin and enterolobin may also use an amphipathic β-hairpin structure to form their transmembrane pore.
It has been previously suggested (13, 27 ) that the D4 β-sandwich of aerolysin forms a hydrophobic dagger that penetrates and forms the membrane pore. D3 and D4
of AT and aerolysin, respectively, (Figure 1 ) contain the propeptides of these two toxins and the proteolytic cleavage of the propeptide has been shown to be essential for toxin oligomerization, presumably by exposing sites protected by the propeptide (12, 39, 40) .
Although we cannot rule out a superficial interaction of some residues within D3 of AT (D4 of aerolysin) with the membrane, the data herein do not support a role for D3 as the TMD of AT. Also, the fact that we can delete the D2 loop of AT and maintain its ability to bind and oligomerize without pore formation is also consistent with the previously established role of D3 in the oligomerization of AT (39) and D4 in the oligomerization of aerolysin (12, 39, 40) , (13) .
These studies provide the first experimental evidence for the location and structure of the transmembrane domain of a member of the aerolysin family of cytolytic toxins, C. septicum alpha toxin. Similar amphipathic regions also exist within the structures of the related aerolysin and enterolobin toxins suggesting that they may also utilize an amphipathic β-hairpin to span the bilayer. Therefore, we propose that this family of toxins belongs to the β-pore-forming class of toxins (41) that utilize an amphipathic β-hairpin to form a membrane-spanning β-barrel. Regions are color coded as follows: green, D1; purple, D2; cyan, D3; yellow, D4; orange, putative TMD; red, propeptide. 
